BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vyteris, Inc. 

13-01 Pollitt Drive

Fair Lawn  New Jersey  07410  U.S.A.
Phone: 201-703-2299 Fax: 201-703-2295


SEARCH JOBS




Industry
Biotechnology

Segment
Drug Delivery





 Company News
Vyteris, Inc. Wants Out of Delivery Tech Biz and into CRO Sector 5/25/2011 8:12:35 AM
Vyteris, Inc. Closes Merger with MediSync BioServices 4/18/2011 9:13:24 AM
Gene E. Burleson, Healthcare Industry Executive and Director of Several NYSE-Listed Companies, Joins Vyteris, Inc. Board of Directors 12/16/2010 9:09:28 AM
Vyteris, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference 11/10/2010 9:41:48 AM
Vyteris, Inc. Receives $489,000 Grant Under the U.S. Qualifying Therapeutic Discovery Project Program 11/9/2010 8:58:56 AM
Vyteris, Inc. Announces Definitive Agreement to Merge With Medisyn Technologies, Inc. 9/13/2010 11:47:24 AM
Vyteris, Inc. to Present at Vyteris, Inc. Annual Global Investment Conference 9/7/2010 10:37:42 AM
Vyteris, Inc. and Georgia Tech Enter Into Exclusive Agreement for Transdermal Drug Delivery Technologies 8/24/2010 9:51:22 AM
Vyteris, Inc. Announces Positive Results From Phase II Clinical Trial of Transdermal Patch for Female Infertility 8/10/2010 7:17:21 AM
Vyteris, Inc. Close to Signing $20 Million Deal for Product to Treat Female Infertility 8/6/2010 6:53:15 AM
123456